First Aid Kit with Burn Cream Recalled for Bacterial Contamination
GFA Production is recalling Adventure First Aid 1.0 kits containing Easy Care After Burn Cream due to confirmed bacterial contamination found in FDA testing. The affected product was distributed nationwide and in Canada.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: FDA Class I classification for confirmed bacterial contamination in a non-sterile topical product. Per the rubric, FDA Class I status mandates the highest severity score, indicating a serious health hazard.
Plain-English summary
GFA Production Xiamen Co. Ltd. is recalling Adventure First Aid 1.0 First Aid Kits containing Easy Care After Burn Cream 0.9 g packets due to confirmed contamination with Bacillus lichenformis and Bacillus sonorensis. FDA laboratory testing identified microbial contamination in the non-sterile product, triggering a Class I recall.
The recall affects 60,048 packets distributed nationwide and in Canada. The affected lot numbers are W06C05 (expiration 03/05/2024), W06F10 (expiration 06/10/2024), and W06H15 (expiration 08/15/2024). The product number is 0120-0213.
Consumers should contact GFA Production Xiamen Co. Ltd. for information regarding this recall.
The recalled product
- Product
- Adventure First Aid 1.0, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 0120-0213
- Manufacturer
- GFA Production Xiamen Co. Ltd.
- Category
- Drug — Topical Cream
- Hazard
- bacterial-contamination
- bacillus-lichenformis
- bacillus-sonorensis
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: W06C05
- exp 03/05/2024
- W06F10
- exp 06/10/2024
- W06H15
- exp 08/15/2024.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27